Orally, preferably with meals to minimize gastrointestinal discomfort. Swallow the tablet whole with water.

Betahistine acts as a weak histamine H1 receptor agonist and a strong histamine H3 receptor antagonist. This dual action is believed to improve microcirculation in the inner ear by relaxing the precapillary sphincters, thus increasing blood flow to the stria vascularis. It may also facilitate histamine release from histaminergic neurons, leading to increased neuronal activity in the vestibular nuclei, which helps reduce vertigo symptoms.

• •Known hypersensitivity to Betahistine or any component of the formulation
• •Phaeochromocytoma (a tumor of the adrenal gland)

Store in a cool, dry place below 30°C, away from light and moisture. Keep out of reach of children.

Symptoms of overdose may include nausea, vomiting, abdominal pain, dizziness, somnolence, and seizures at very high doses. Treatment is symptomatic and supportive, with gastric lavage and activated charcoal if appropriate.

Pregnancy: There are no adequate data from the use of betahistine in pregnant women. Animal studies are insufficient. Not recommended during pregnancy unless clearly necessary. Lactation: It is unknown whether betahistine is excreted in human breast milk. A decision should be made whether to discontinue breastfeeding or to discontinue betahistine therapy, taking into account the benefit of breastfeeding for the child and the benefit of therapy for the mother.